Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on US Healthcare Journal.
Press releases published on March 28, 2025
Curium completa la adquisición de Monrol como parte de su plan para expandir significativamente la capacidad de lutecio-177 y presencia PET
GlobeNewswire
·
March 28, 2025
Posiciona a Curium como fabricante líder de isótopo Lu-177 Aporta experiencia innovadora en I+D y una línea de desarrollo de productos a Curium Mejora la cobertura geográfica y la cadena de suministro de SPECT y PET de Curium PARÍS, March 29, 2025 (GLOBE …
Curium schließt Übernahme von Monrol im Rahmen seines Plans zur erheblichen Ausweitung der Lutetium-177-Kapazitäten und der Präsenz im Bereich der Positronen-Emissions-Tomographie (PET) ab
GlobeNewswire
·
March 28, 2025
Dies positioniert Curium als führenden Hersteller des Isotops Lu-177 Integration innovativer F…
Curium finalise l’acquisition de Monrol, axée sur le net renforcement de sa capacité de production de lutécium-177 et de son empreinte PET
GlobeNewswire
·
March 28, 2025
Affirmation de son leadership dans la production de l’isotope lutétium-177 Renforcement de son expertise en R…
Curium משלימה את רכישת Monrol כחלק מהתוכנית שלה להרחיב משמעותית את הקיבולת של לוטיציום-177 וטביעת הרגל של השימוש ב-PET
GlobeNewswire
·
March 28, 2025
*תמצב את Curium כיצרנית מובילה של איזוטופ לוטיציום-177 *מביאה מומחיות מו"פ חדשנית וצנרת ייצור ל-Curium *משפרת את הכיסוי הגיאוגרפי ואת שרשרת האספקה של עבור ה-SPECT …
キュリウム (Curium)、ルテチウム177の供給能力およびPET分野の事業拡大計画の一環としてモンロール (Monrol) の買収を完了
GlobeNewswire
·
March 28, 2025
キュリウムは、ルテチウム177アイソトープの主要製造企業としての地位を確立 革新的な研究開発の専門性および開発パイプラインをキュリウムにもたらす SPECTおよびPETにおけるキュリウムの地理的展開とサプライチェーンを強化 パリ発, March 29, 2025 (GLOBE NEWSWIRE) -- 核医学の世界的リーダーであるキュリウム・ファーマ (Curium Pharma) (「キュリウム」) …
Curium, 루테튬-177 생산 능력과 PET 풋프린트의 대폭 확대 위한 계획의 일환으로 Monrol 인수 완료
GlobeNewswire
·
March 28, 2025
Curium, 루테튬-177 동위원소 선도적 제조업체로 자리매김 Curium은 혁신적인 R…
Curium Menyelesaikan Akuisisi Monrol sebagai Bagian dari Rencananya untuk Secara Signifikan Meningkatkan Kapasitas Lutetium-177 dan Jaringan PET
GlobeNewswire
·
March 28, 2025
Menempatkan Curium sebagai produsen terkemuka isotop Lu-177 Memberikan keahlian Litbang dan rangkaian tahap pengembangan produk (pipeline) yang inovatif ke Curium Meningkatkan jangkauan geografis dan rantai pasokan SPECT …
Curium Menyelesaikan Pemerolehan Monrol sebagai Sebahagian daripada Rancangannya untuk Memperluaskan Kapasiti Lutetium-177 dan Jejak PET Dengan Ketara
GlobeNewswire
·
March 28, 2025
Meletakkan Curium sebagai pengeluar terkemuka isotop Lu-177 Membawa kepakaran dan saluran paip R…
Curium Finaliza a Aquisição da Monrol como Parte do seu Plano para Expandir Significativamente a Capacidade de Lutécio-177 e Pegada PET
GlobeNewswire
·
March 28, 2025
Aquisição posiciona a Curium como principal fabricante do isótopo Lu-177 Oferece experiência inovadora em P…
Curium เสร็จสิ้นการเข้าซื้อ Monrol ซึ่งเป็นส่วนหนึ่งของแผนการขยายกำลังการผลิต Lutetium-177 และฐานการผลิต PET อย่างมีนัยสำคั…
GlobeNewswire
·
March 28, 2025
วางตำแหน่ง Curium เป็นผู้ผลิตไอโซโทป Lu-177 ชั้นนำ นำความเชี่ยวชาญด้านการวิจัยและพัฒนาที่เป็นนวัตกรรมและลำดับขั้นตอนการทำงานมาสู่ Curium เพิ่มความครอบคลุมทางภูมิศาสตร์และห่วงโซ่อุปทาน SPECT …
Curium 完成收購 Monrol，以實現大幅擴大鑥-177 產能及 PET 業務範圍的計劃
GlobeNewswire
·
March 28, 2025
將 Curium 定位為領先的 Lu-177 同位素製造商 為 Curium 帶來創新的研發專業知識和產品線 增強 Curium 的 SPECT 和 PET 地理覆蓋和供應鏈 巴黎, March 29, 2025 (GLOBE NEWSWIRE) -- 全球核醫學領導者 Curium Pharma（「Curium」）欣然宣佈已完成收購 Eczacıbaşı-Monrol Nuclear Products Co. (Monrol)。Monrol 是一家領先的核醫學公司，總部位於土耳其伊斯坦堡。 此次收購增強了 …
Curium 完成对 Monrol 的收购，其镥-177 产能及 PET 业务范围大幅扩大
GlobeNewswire
·
March 28, 2025
确立了 Curium 的镥-177 同位素领先制造商地位 为 Curium 注入创新的研发专业技术和产品管线 拓展 Curium 的 SPECT 和 PET 地理覆盖范围和供应链 巴黎, March 29, 2025 (GLOBE NEWSWIRE) -- 全球核医学领域领导者 Curium Pharma (“Curium”) 宣布完成对 Eczacıbaşı-Monrol Nuclear Products Co. (Monrol) 的收购，后者也是核医学领域的领先企业，总部位于土耳其伊斯坦布尔。 …
Safety Shot, Inc. Announces Record Date for Spin-Off and Distribution of Shares Common Stock of Caring Brands, Inc. - Updated
GlobeNewswire
·
March 28, 2025
JUPITER, FL, March 28, 2025 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) (the “Company” or “Safety Shot”), today announced that the record date for the spin-off and distribution of shares of common stock, par value $0.0001 per share, (“Caring …
PowerDMARC Named Grid Leader for DMARC in G2 Spring Reports 2025
EIN Presswire
·
March 28, 2025
PowerDMARC wins several accolades across the board in G2 Spring 2025 Reports, including Regional Leader in Asia Pacific …
Hudson Therapeutics and Shaperon Deepen Licensing Discussions for NuGel Following Bio Europe Spring 2025
EIN Presswire
·
March 28, 2025
Due Diligence underway as clinical data of NuGel, Atopic Dermatitis Treatment is shared for in-depth licensing out discussion DURHAM, NC, UNITED STATES, March 28, 2025 /EINPresswire.com/ -- Hudson Therapeutics, the U.S. subsidiary of Shaperon, today …
Dr. Mohana Rao Patibandla (Dr. Rao) Honored as Best Minimally Invasive Neurosurgeon and Spine Surgeon in India
EIN Presswire
·
March 28, 2025
Dr. Mohana Rao Patibandla (Dr. Rao) Honored as Best Minimally Invasive Neurosurgeon and Spine Surgeon in India GUNTUR, ANDHRA PRADESH, INDIA, March 28, 2025 /EINPresswire.com/ -- Dr. Mohana Rao Patibandla Receives Award for Best Minimally Invasive …
Alfa Chemistry Testing Lab Unveils Extensive Surfactant Testing Services in Holbrook, NY
EIN Presswire
·
March 28, 2025
NEW YORK, NY, UNITED STATES, March 28, 2025 /EINPresswire.com/ -- Alfa Chemistry Testing Lab from Holbrook, NY unveils its expanded surfactant testing capabilities which aim to serve the varied needs of worldwide industries. Their extensive services …
Business Reporter: Best of British Business campaign - The power of real-time call data analytics
EIN Presswire
·
March 28, 2025
How businesses can improve their performance by taking phone calls seriously LONDON, UNITED KINGDOM, March 28, 2025 /EINPresswire.com/ -- Akixi, a leading provider of CX insights, has been named a 2025 Best of British Business winner by Business …
HilleVax Reports Full Year 2024 Financial Results and Highlights Recent Company Progress
GlobeNewswire
·
March 28, 2025
$171.4 million of cash, cash equivalents and marketable securities as of December 31, 2024 The company is exploring the potential for continued development of its norovirus vaccine candidates in adults as well as business development related activities and …
Mitolyn Reviews (DOCTOR INVESTIGATION REVEALS): What Medical Experts Discovered About Its Fat-Burning & Cellular Impact
GlobeNewswire
·
March 28, 2025
Orlando, FL, March 28, 2025 (GLOBE NEWSWIRE) -- Mitolyn When it comes to weight loss supplements, consumer experiences and real-world results matter more than marketing hype. With Mitolyn gaining rapid attention, people are asking the same questions: Does …